The Delivery Strategy of Paclitaxel Nanostructured Lipid Carrier Coated with Platelet Membrane

cellular uptake of targeted nanostructured lipid carrier (nlc) and cytotoxicity evaluation of encapsulated paclitaxel in ht29 cancer cells

Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases

Buparvaquone (BPQ), a veterinary drug, was formulated as nanostructured lipid carriers (NLC) for leishmaniases treatment. The formulation design addressed poor water solubility of BPQ and lack of human drug delivery system. The DSC/TG and microscopy methods were used for solid lipids screening. Softisan® 154 showed highest BPQ solubility in both methods. The BPQ solubility in liquid lipids usin...

Characterization and toxicity of citral incorporated with nanostructured lipid carrier

The nanoparticle as a cancer drug delivery vehicle is rapidly under investigation due to its promising applicability as a novel drug delivery system for anticancer agents. This study describes the development, characterization and toxicity studies of a nanostructured lipid carrier (NLC) system for citral. Citral was loaded into the NLC using high pressure homogenization methods. The characteriz...

1. Nanostructured lipid carrier for bioavailability enhancement

Nanostructred lipid carrier(NLC) is second generation drug carrier system having solid matrix at room temperature. This carrier system is made up of physiological, biodegradable and biocompatible lipid materials and surfactants and is accepted by regulatory authorities for application in different drug delivery system. The main objective of this review is to explore the role of NLCs system for ...

Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil

The aim of this study was to develop a nanostructured lipid carrier (NLC)-based hydrogel and study its potential for the topical delivery of 5-fluorouracil (5-FU). Precirol® ATO 5 (glyceryl palmitostearate) and Labrasol® were selected as the solid and liquid lipid phases, respectively. Poloxamer 188 and Solutol® HS15 (polyoxyl-15-hydroxystearate) were selected as surfactants. The developed lipi...